RE:Interesting perspective
Hey
I'm with you guys. But I'm just pointing out that there is a mass of investors that are not getting to this stock (yet) because it has issues, hopefully more in the past. Even reading the CR results is confusing because there is optimized and non-optimized because they messed up and underdosed a bunch of patients AND removed them from the trial prematurely.
The plus side is that if they hadn't messed things up like this many of us late arrivals to this company (I'm a Summer 2020 start person, so not long holder but not newbie either) wouldn't have gotten in at a good price.
Just sharing as an interesting perspective on what a novice would see if they googled for the first time.
Good luck to all.
DJ